Market News AIOpen the app

CRISPR Therapeutics AG shares news about new leaders and Andrew J. Silver becoming the Chief Financial Officer right away.

New bossRead the original at SEC EDGAR
Neutral

CRSP promoted a finance executive who has worked there since 2018, supporting continuity. His salary, bonus target, and share award add compensation costs, but the filing reports no change to its medicines or business results.

CRSP · CRISPR Therapeutics AG

AI read · Neutral

The AI's read

Silver's years in finance roles at CRSP may help keep its accounting and planning steady. The promotion also brings a salary, bonus target, and share award. Those add compensation costs, but the filing gives no update on CRSP's medicines or business results. This personnel change alone does not alter the company's outlook.

Get alerts for CRSP

Follow CRISPR Therapeutics AG (CRSP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CRSP
Free on the App Store and Google Play, or on the web.